Showing results (41-50 of 721) with videos related to
Sort By:
Pageof 73
The Lancet. Haematology|November 4, 2018
Moderate-intensity endurance-exercise training in patients with sickle-cell disease without severe chronic complications (EXDRE): an open-label randomised controlled trialBarnabas Gellen, Laurent A Messonnier, Frédéric Galactéros, et al.The Lancet. Haematology|August 25, 2022
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trialAli T Taher, Maria Domenica Cappellini, Antonis Kattamis, et al.The Lancet. Haematology|March 25, 2021
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trialAntonio M Risitano, Alexander Röth, Juliette Soret, et al.The Lancet. Haematology|January 19, 2025
Low-dose aspirin versus placebo in postpartum venous thromboembolism: a multi-national, pilot, randomised, placebo-controlled trialLeslie Skeith, A Kinga Malinowski, Darine El-Chaâr, et al.The Lancet. Haematology|March 8, 2025
Epidemiology, clinical features, and outcomes of peripheral T-cell lymphoma in Latin America: an international, retrospective, cohort studyLuis Malpica, Henry Idrobo, Astrid Pavlovsky, et al.The Lancet. Haematology|December 11, 2024
Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trialJuan Pablo Alderuccio, Alvaro J Alencar, Jonathan H Schatz, et al.The Lancet. Haematology|October 11, 2024
Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic SyndromesRami S Komrokji, Luca Lanino, Somedeb Ball, et al.The Lancet. Haematology|November 7, 2024
Accelerating and optimising CAR T-cell manufacture to deliver better patient productsGiulia Agliardi, Juliana Dias, Alexandros Rampotas, et al.The Lancet. Haematology|November 27, 2022
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort studyPageof 73